These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10213575)

  • 1. Immunogenicity of low-dose plasma-derived hepatitis B vaccine.
    Kane M; Milstien J
    Lancet; 1997 Oct; 350(9084):1102. PubMed ID: 10213575
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity of a low dose of indigenously developed recombinant hepatitis-B vaccine in neonates and infants.
    Rao MN; Joshi N; Habibullah CM
    Indian Pediatr; 1999 Jun; 36(6):581-3. PubMed ID: 10736587
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenicity and safety of yeast-derived recombinant hepatitis B vaccine (Heberbiovac HB) in South African children.
    Mphahlele MJ; Burnett RJ; Kyaw T; Schoeman HS; Aspinall S
    S Afr Med J; 2004 Apr; 94(4):280-1. PubMed ID: 15150941
    [No Abstract]   [Full Text] [Related]  

  • 4. [The pediatrician and the hepatitis B vaccine].
    Mussa GC; Silvestro L; Mussa F
    Minerva Pediatr; 1994 Nov; 46(11):475-80. PubMed ID: 7870007
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity of hepatitis B vaccine incorporated into the expanded program of immunization schedule.
    Gomber S; Sharma R; Ramachandran VG; Talwar V; Singh B
    Indian Pediatr; 2000 Apr; 37(4):411-3. PubMed ID: 10781235
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunity to hepatitis B in two birth cohorts given plasma-derived or yeast-derived vaccine.
    Salmond CE; Bandaranayake DR; Tobias M
    N Z Med J; 1999 Sep; 112(1095):331-3. PubMed ID: 10553933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
    Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN
    J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B vaccine.
    John TJ
    Indian Pediatr; 1995 Jun; 32(6):715-8. PubMed ID: 8613350
    [No Abstract]   [Full Text] [Related]  

  • 10. Duration of protection after infant hepatitis B vaccination series.
    Middleman AB; Baker CJ; Kozinetz CA; Kamili S; Nguyen C; Hu DJ; Spradling PR
    Pediatrics; 2014 Jun; 133(6):e1500-7. PubMed ID: 24843060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
    Van Damme P; Van Herck K
    Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of a Chinese hamster ovary cell derived hepatitis B vaccine in Chinese rural communities.
    Zhang Y; Ma JC; Qi SX; Wang F; Zhao C; Bi SL
    Vaccine; 2011 May; 29(22):3905-8. PubMed ID: 21457729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the status of immune memory after completion of hepatitis B vaccination].
    Li YP; Li RC; Fang KX; Li HM; Hu ZY; He P; Wu XY; Zhang R; Liang ZL; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Apr; 28(4):319-21. PubMed ID: 17850693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical efficacy and immunologic responses of hepatitis B vaccination in very-low-birth-weight infants.
    Yang YJ; Lin CH; Tai YT; Huang SC; Lin YJ
    Pediatr Infect Dis J; 2008 Aug; 27(8):768. PubMed ID: 18574432
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenicity of recombinant hepatitis B vaccine in thalassemic children.
    Sethi GR; Sharma S; Sudha S; Rishi RK
    Indian Pediatr; 1999 May; 36(5):498-501. PubMed ID: 10728041
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatitis B vaccine].
    Rev Saude Publica; 2006 Dec; 40(6):1137-40. PubMed ID: 17173175
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenic response to hepatitis B vaccine in Indian infants.
    Karthikeyan G
    Indian Pediatr; 1998 Apr; 35(4):375-6; discussion 376-7. PubMed ID: 9770898
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity of a low-cost hepatitis B vaccine in the South African Expanded Programme on Immunisation.
    Aspinall S; Kocks DJ
    S Afr Med J; 1998 Jan; 88(1):36-9. PubMed ID: 9539933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective antibody after a 'one dollar' hepatitis B vaccine.
    Kalayanarooj S; Vaughn DW; Ariyasriwatana C; Snitbhan R
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):659-63. PubMed ID: 9253863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.